Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 17;19(12):4081.
doi: 10.3390/ijms19124081.

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension

Kimio Satoh  1 , Nobuhiro Kikuchi  2 , Taijyu Satoh  3 , Ryo Kurosawa  4 , Shinichiro Sunamura  5 , Mohammad Abdul Hai Siddique  6 , Junichi Omura  7 , Nobuhiro Yaoita  8 , Hiroaki Shimokawa  9
Affiliations
Review

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension

Kimio Satoh et al. Int J Mol Sci. .

Abstract

Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are fatal diseases; however, their pathogenesis still remains to be elucidated. We have recently screened novel pathogenic molecules and have performed drug discovery targeting those molecules. Pulmonary artery smooth muscle cells (PASMCs) in patients with PAH (PAH-PASMCs) have high proliferative properties like cancer cells, which leads to thickening and narrowing of distal pulmonary arteries. Thus, we conducted a comprehensive analysis of PAH-PASMCs and lung tissues to search for novel pathogenic proteins. We validated the pathogenic role of the selected proteins by using tissue-specific knockout mice. To confirm its clinical significance, we used patient-derived blood samples to evaluate the potential as a biomarker for diagnosis and prognosis. Finally, we conducted a high throughput screening and found inhibitors for the pathogenic proteins.

Keywords: biomarker; drug discovery; pathogenesis; pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Screening of novel therapeutic targets for pulmonary arterial hypertension and schematic representation of the role of selenoprotein P (SeP). Volcano plots of gene expression variations in PAH-PASMCs and control PASMCs. Blue plots represent probes for SeP. Dashed lines represent an adjusted P value of 0.05 and ± 1-fold change. PAH-PASMCs, pulmonary artery smooth muscle cells harvested from patients with pulmonary arterial hypertension (PAH); ApoER2, apolipoprotein E receptor 2; ERK1/2, extracellular signal regulated kinases 1 and 2; ETC, electron transport chain; FOXO3a, forkhead box protein O3a; GSH, glutathione; GSSG, oxidized glutathione; HIF-1α, hypoxia inducible factor 1α; PAH-PASMCs, pulmonary arterial hypertension-pulmonary artery smooth muscle cells; ROS, reactive oxygen species; SeP, selenoprotein P; TCA cycle, tricarboxylic acid cycle.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J. Clin. Investig. 2012;122:4306–4313. doi: 10.1172/JCI60658. - DOI - PMC - PubMed
    1. Austin E.D., Loyd J.E. The genetics of pulmonary arterial hypertension. Circ. Res. 2014;115:189–202. doi: 10.1161/CIRCRESAHA.115.303404. - DOI - PMC - PubMed
    1. Kholdani C., Fares W.H., Mohsenin V. Pulmonary hypertension in obstructive sleep apnea: Is it clinically significant? A critical analysis of the association and pathophysiology. Pulm. Circ. 2015;5:220–227. doi: 10.1086/679995. - DOI - PMC - PubMed
    1. Hoeper M.M., Humbert M., Souza R., Idrees M., Kawut S.M., Sliwa-Hahnle K., Jing Z.-C., Gibbs J.S.R. A global view of pulmonary hypertension. Lancet Respir. Med. 2016;4:306–322. doi: 10.1016/S2213-2600(15)00543-3. - DOI - PubMed
    1. Jiang X., Yuan L., Li P., Wang J., Wang P., Zhang L., Sun B., Sun W. Effect of simvastatin on 5-HT and 5-HTT in a rat model of pulmonary artery hypertension. Cell. Physiol. Biochem. 2015;37:1712–1724. doi: 10.1159/000438536. - DOI - PubMed

MeSH terms